Science & Validation

Grounded in Systems Science and Quantitative Disease Modeling

BioTraject Systems approaches chronic disease as a dynamic, evolving process rather than a static risk state.

Our work is grounded in established scientific disciplines, including systems dynamics and state-space modeling informed by stochastic process theory, control theory, epidemiology, biostatistics, and machine learning. Together, these disciplines support trajectory-based simulation of disease progression, intervention effects, and long-term outcomes.

This foundation enables explicit representation of time, uncertainty, feedback, and intervention—core features of chronic disease that are difficult to capture using snapshot-based or purely correlational approaches.

Our approach is further informed by clinical science, health data science, and computational modeling, ensuring that models reflect real-world data structures and clinical plausibility.

A Validation-First Philosophy

Scientific rigor and validation are foundational to BioTraject Systems.

Rather than treating validation as a downstream step, the BioTraject platform and its disease-specific products are being designed with validation embedded throughout development. Model assumptions, structures, and behaviors are intended to be explicit and examinable.

The goal is not simply to generate predictions, but to construct simulation models whose behavior can be interrogated, stress-tested, and refined through systematic evaluation.

Validation Framework

BioTraject Systems is developing a structured validation framework that will be applied consistently across disease domains and products as they mature.

This framework includes the following components:

Model Structure Evaluation

Face-validity assessment with clinical and domain experts
Evaluation of biological and clinical plausibility
Explicit documentation of structural assumptions

Parameter Calibration

Calibration using curated longitudinal datasets
Evaluation of parameter stability across populations and subgroups
Quantification of parameter uncertainty

Internal Consistency and Sensitivity

Verification of model behavior under known or limiting conditions
Sensitivity and stress testing of model components
Examination of emergent system dynamics

Scenario and Counterfactual Testing

Simulation of alternative intervention timing and sequencing
Exploration of competing risks and downstream consequences
Assessment of system behavior under counterfactual conditions

External Benchmarking

Comparison with established epidemiologic findings
Evaluation using independent datasets where available
Alignment with observed longitudinal disease patterns

Data Foundations

Model development and validation are supported by curated longitudinal datasets, including:

EHR-derived real-world data
Observational cohort studies
Clinical trial datasets
Disease registries

These data sources are used for research, development, calibration, sensitivity analysis, and benchmarking within a controlled scientific environment.

Transparency, Interpretability, and Uncertainty

Interpretability is treated as a scientific requirement rather than an optional feature.

The BioTraject Systems Computational Medicine Platform emphasizes:

Explicit state definitions and system structure
Transparent representation of stochastic components and uncertainty
Clearly documented assumptions and parameterization strategies
Reproducible simulation workflows

Uncertainty is propagated through simulated trajectories rather than collapsed into single-point estimates, enabling more informative exploration of disease behavior and intervention effects.

Product-Specific Validation

While the BioTraject Systems Computational Medicine Platform provides a shared methodological foundation, each disease-specific product incorporates additional domain-specific validation steps.

For NephroSync™, this includes validation approaches tailored to kidney disease progression, acute event dynamics, comorbidity interactions, and long-term outcome trajectories.

As additional disease domains are incorporated, each product will follow the same overarching validation framework while integrating domain-appropriate evaluation criteria.

Designed for Scientific Scrutiny

BioTraject Systems develops its models with the expectation that they will be examined by clinicians, researchers, reviewers, and, ultimately, regulators.

Our development philosophy emphasizes:

Methodological rigor
Reproducibility
Explicit articulation of limitations and uncertainty
Iterative refinement informed by evidence

Scientific scrutiny is treated as an integral part of development rather than a post-hoc requirement.

Validation as an Ongoing Process

As products mature, BioTraject Systems anticipates disseminating methodological work, validation analyses, and domain-specific findings consistent with best practices in epidemiologic and clinical research.

Validation is not a single milestone, but an ongoing process as models evolve, data sources expand, and new disease domains are incorporated.

Explore Further

Technology – Learn about the BioTraject Platform
NephroSync™ – Explore our first product under development
Company – Learn why BioTraject Systems was founded

Contact us to discuss scientific collaboration, advisory roles, or validation partnership